Wnt signaling is well known for its involvement in development and athogenesis.
Studies by Scheller et al. and by Kirstetter et al. in Nature Immunology now show that
transgenic expression of a stable form of ß-
catenin blocks
differentiation of murine HSCs.To elucidate the consequences of conditionally overexpressed wild type ß-catenin in mice, both groups designed a conditional expression system without retroviral or oncogenic components. Intheir studies, FACS analysis indicated that the differentiation of HSCs was arrested at early blood
cell progenitor stages, leading to fatal anemia in the transgenic mice. Using rt-PCR analysis, Kirstetter et al. discovered that the genes responsible for HSC population expansion and myeloid progenitor formation were significantly downregulated. However, the block of erythroid differentiation was due to ectopic PU.1 expression causing GATA-1 downregulation.Scheller et al. in turn showed that transgenic HSCs had increased levels of cyclins E1 and E2 and reduced expression of the CDK inhibitory kinase p21kip/waf, which is essential for maintaining resting HSCs. Thus, the presence of ß-catenin enables HSCs to enter the cell cycle but depletes the stem cell reservoir, resulting in a loss of long-term engraftment capacity.The exhaustion rather than the renewal of the HSC population indicates that Wnt signaling is not sufficient for leukemic transformation. As components of the Wnt pathway are upregulated in several types of leukemia, the results of these two studies may allow targeting leukemic cells without disturbing HSCs by altering the Wnt pathway.
More reviews about the What a stem cell Wnts